PapersPMID:38931273
Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials.
- findings
- 5
- compound
- 1
- endpoints
- 5
- no difference found
- 1
- Study, every finding
- meta-analysis
- Dose studied, every finding
- daily cocoa intake 1.4 to 50.0 g across trials
What moved
How to read these marks →“The overall analysis of the effect of cocoa consumption on blood pressure involved 22 studies (n = 1224) and showed a reduction in SBP of −2.52 mmHg (95% CI −4.17 to −0.88 mmHg) and a reduction in DBP of −1.58 mmHg (95% CI −2.54 to −0.62 mmHg).”
- Participants
- 1,224
- Effect
- −2.52 mean difference, 95% CI −4.17 to −0.88
- Population
- Adults aged 18 or over, healthy or with cardiometabolic risk factors; 22 pooled randomised trials of 4 weeks or longer
- Participants
- 1,224
- Effect
- −1.58 mean difference, 95% CI −2.54 to −0.62
- Population
- Adults aged 18 or over, healthy or with cardiometabolic risk factors; 22 pooled randomised trials of 4 weeks or longer
- Decreases total cholesterol (TC)
moderate
“Dietary cocoa consumption effectively reduced total cholesterol by −8.35 mg/dL (95% CI −14.01 to −2.69 mg/dL).”
- Effect
- −8.35 mean difference, 95% CI −14.01 to −2.69
- Population
- Adults aged 18 or over, healthy or with cardiometabolic risk factors; pooled randomised trials of 4 weeks or longer
- Decreases LDL cholesterol
moderate
“The analysis showed a reduction in LDL-c of −9.47 mg/dL (95% CI −13.75 to −5.20) with cocoa consumption.”
- Effect
- −9.47 mean difference, 95% CI −13.75 to −5.2
- Population
- Adults aged 18 or over, healthy or with cardiometabolic risk factors; pooled randomised trials of 4 weeks or longer, one outlier study excluded
What did not
“The other outcome of interest in glucose metabolism was HbA1c, and the results showed no effect of cocoa consumption on HbA1c.”
- Population
- Adults aged 18 or over, healthy or with cardiometabolic risk factors; pooled randomised trials of 4 weeks or longer, few studies
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Adults aged 18 and over, healthy or with cardiometabolic risk factors, in 31 randomized trials of cocoa extract or dark chocolate of 70% cocoa or more
- Participants
- 1,986
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 20